Compile Data Set for Download or QSAR
Report error Found 106 Enz. Inhib. hit(s) with all data for entry = 9371
TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461806(3,4-Dimethylphenyl 3-deoxy-3-[4-(3,4,5-triflooroph...)
Affinity DataKd:  150nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461807(3-Bromophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)...)
Affinity DataKd:  37nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461808(3-Ethoxyphenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  420nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461809(4-Pyridyl 3-deoxy-1-thio-3-[4-(3,4,5-trifluorophen...)
Affinity DataKd:  190nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461810(2,4-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  650nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461811(4-Acetanilidyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  313nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461812(4-Methoxyphenyl 3-deoxy-3-[4-(3,4,5-trifluoropheny...)
Affinity DataKd:  410nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461813(2,3-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  530nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461814(3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-triflooroph...)
Affinity DataKd:  17nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461815(Benzyl 3-deoxy-1-thio-3-[4-(3,4,5-trifloorophenyl)...)
Affinity DataKd:  1.13E+3nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461816(3-Methoxyphenyl 3-deoxy-3-[4-(3,4,5-trifluoropheny...)
Affinity DataKd:  270nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461817(2-Naphtyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-...)
Affinity DataKd:  180nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461818(3-Methylphenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  240nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461819(3-(Trifluoromethyl)phenyl 3-deoxy-3-[4-(3,4,5-trif...)
Affinity DataKd:  130nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461820(4-Bromophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)...)
Affinity DataKd:  520nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461821(3,5-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  80nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461822(2,6-Dimethylphenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  1.58E+3nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461823(1-Naphthyl 3-deoxy-1-thio-3-[4-(3,4,5-trifluorophe...)
Affinity DataKd:  960nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461824(3-Chlorophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  49nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461825(3-(Trifluoromethoxy)phenyl 3-deoxy-3-[4-(3,4,5-tri...)
Affinity DataKd:  500nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461826(2-Pyridyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl-1H-1...)
Affinity DataKd:  510nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461827(1-O-(3,4-Dichlorophenyl) 3-deoxy-3-[4-(3,4,5-trifl...)
Affinity DataKd:  490nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461828(4-Chlorophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  200nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461829(3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  10nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461830(3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  62nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461831(4-Chlorophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  770nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461832(Phenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2...)
Affinity DataKd:  400nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461833(3-Chloro-4-fluorophenyl 3-deoxy-3-[4-(3,4,5-triflu...)
Affinity DataKd:  48nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461834(4-Tolyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,...)
Affinity DataKd:  460nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461835(4-Fluorophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  270nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461836(4-Trifluoromethoxyphenyl 3-deoxy-3-[4-(3,4,5-trifl...)
Affinity DataKd:  280nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461837(Phenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2...)
Affinity DataKd:  1.00E+3nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461838(3-Chlorophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  250nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461839(3-Chlorophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  570nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461840(Cyclohexyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H...)
Affinity DataKd:  440nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461841(2,4,5-Trichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluor...)
Affinity DataKd:  60nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461842(2,5-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  84nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461843(3-Hydroxy-phenyl 3-deoxy-3-[4-(3,4,5-trifluorophen...)
Affinity DataKd:  490nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461844(3-Bromophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)...)
Affinity DataKd:  23nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461845(2-Phenethyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1...)
Affinity DataKd:  480nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461846(3,4-Dichlorophenyl 3-O-[(2-amino-(4-chlorophenyl) ...)
Affinity DataKd:  1.30E+3nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461847(3,4-Dichlorophenyl 3-deoxy-3-[4-(2,3,4,5,6-pentafl...)
Affinity DataKd:  2nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461848(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluoro...)
Affinity DataKd:  35nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461849(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  23nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461850(3-Chloro-5-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluo...)
Affinity DataKd:  41nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461851(3-Chloro-4-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluo...)
Affinity DataKd:  31nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461852(3-Chloro-6-fluoro-4-cyanophenyl 3-deoxy-3-[4-(3,4,...)
Affinity DataKd:  29nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461853(3-Bromo-4-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluor...)
Affinity DataKd:  43nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461854(5-Bromo-6-trifluoromethyl-pyridin-3-yl 3-deoxy-3-[...)
Affinity DataKd:  23nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461855(5-Chloro-6-cyano-pyridin-3-yl 3-deoxy-3-[4-(3,4,5-...)
Affinity DataKd:  39nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 106 total ) | Next | Last >>
Jump to: